Google Custom Search

FDA Warns Companies Selling Drugs on the Internet that Falsely Claim to Prevent and Treat STDs, including HIV/AIDS

The U.S. Food and Drug Administration (FDA) recently issued warning letters to 6 U.S. companies and 1 foreign individual for marketing unapproved and misbranded drugs over the Internet for the prevention and treatment of sexually transmitted diseases (STDs).

The products are being sold as:

Tetrasil
Genisil
Aviralex
OXi-MED
Imulux
Beta-mannan
Micronutrient
iQina
SlicPlus

The sellers falsely claim that their products prevent or treat a variety of STDs, including herpes, chlamydia, human papillomavirus (HPV), cervical dysplasia, and HIV/AIDS.

Some of these products are falsely claimed to have "FDA approval" and some are claimed to be "more effective" than conventional therapies. Examples of such claims include:

"Treatment kills all herpes viruses WITHOUT having to use conventional drugs or medications."

"Greatest STD Protection without Condoms."

"The active ingredient in our product is FDA certified to destroy 99.9992 percent of all pathogenic organisms [i.e.] Chlamydia."

"STDs are very serious diseases and these products give consumers a false sense of security that they are protected from STDs," said Janet Woodcock, MD, Director of the FDA's Center for Drug Evaluation and Research.

What Consumers Should Do

According to the FDA, consumers should take the following steps:

Stop using these products immediately.

Contact a healthcare professional if they have experienced any bad reactions after using these products.

Notify the FDA of any complaints or problems associated with these products through FDA's MedWatch voluntary reporting program at 800-FDA-1088 or www.fda.gov/medwatch/report.htm.

The agency's warning letters state that failure to properly resolve violations of the law with regard to false claims may result in further enforcement actions that may include seizure of illegal products and possible criminal prosecution.

Issuing these warning letters is part of the FDA's ongoing campaign against fraudulent products marketed on the Internet for serious diseases. The agency also works to educate consumers about the risks and dangers related to buying unsafe products.

To view the recent letters, see:

3/14/08

Source
U.S. Food and Drug Administration (FDA). FDA Warns Companies Importing and Marketing Drugs Over the Internet that Fraudulently Claim to Prevent and Treat STDs. Press Release. March 6, 2008.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agenerase
Agenerase (amprenavir)
Aptivus
Aptivus (tipranavir)
Crixivan
Crixivan (indinavir)
Invirase
Invirase (saquinavir hard gel)
Kaletra
Kaletra (lopinavir/ritonavir)
Lexiva
Lexiva (fosamprenavir)
Norvir
Norvir (ritonavir)
Prezista
Prezista (darunavir)
Reyataz
Reyataz (atazanavir)
Viracept
Viracept (nelfinavir)
Combivir
Combivir (zidovudine/lamivudine)
Epivir
Epivir (lamivudine; 3TC)
Emtriva
Emtriva (emtricitabine; FTC)
Epzicom
Epzicom (abacavir + lamivudine)
Retrovir
Retrovir (zidovudine; AZT)
Trizivir
Trizivir (abacavir + zidovudine +lamivudine)
Truvada
Truvada  (tenofovir / emtricitabine)
Videx
Videx (didanosine; ddI)
Viread
Viread (tenofovir)
Zerit
Zerit (stavudine; d4T)
Ziagen
Ziagen (abacavir)
Rescriptor
Etravirine (Intelence; TMC125)
Rescriptor
Rescriptor (delavirdine)
Sustiva
Sustiva (efavirenz)
Viramune
Viramune (nevirapine)
Fuzeon (enfuvirtide, T-20)
Selzentry ( maraviroc)
Atripla
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir
Combivir (zidovudine + lamivudine)
Trizivir
Trizivir (abacavir + zidovudine + lamivudine)
Truvada
Truvada (tenofovir + emtricitabine)
Isentress (raltegravir)